Lack of an association between alleles of interleukin-1α and interleukin-1 receptor antagonist genes and Graves' disease in a North American Caucasian population

Journal of Clinical Endocrinology and Metabolism

Volumn 81, Issue 12, 1996, Pages 4476-4478

  Cuddihy, R M ^a   Bahn, R S ^a  

^a MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1ALPHA;

ALLELE; ARTICLE; CAUCASIAN; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; GRAVES DISEASE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORTH AMERICA; POPULATION RESEARCH; PRIORITY JOURNAL;

ALLELES; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GRAVES DISEASE; HETEROZYGOTE; HUMANS; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-1; MALE; SIALOGLYCOPROTEINS;

EID: 0029802343     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.81.12.4476     Document Type: Article

References (26)

1. Bech K, Lumholtz B, Nerup J, et al. 1977 HLA antigens in Graves' disease. Acta Endocrinol (Copenh). 86:510-516.
2. Farid NR, Sampson L, Noel EP, et al. 1979 A study of human leukocyte D locus related antigens in Graves' disease. J Clin Invest. 63:108-113.
3. Farid NR, Stone E, Johnson G. 1980 Graves' disease and HLA: clinical and epidemiologic associations. Clin Endocrinol (Oxf). 13:535-544.
4. Dahlberg PA, Holmlund G, Karlsson FA, Safwenberg J. 1981 HLA-A, -B, -C and -DR antigens in patients with Graves' disease and their correlation with signs and clinical course. Acta Endocrinol (Copenh). 97:42-47.
5. Schleusener H, Schernthaner G, Mayr WP, et al. 1983 HLA-DR3 and HLA-DR5 associated thyrotoxicosis-two different types of toxic diffuse goiter. J Clin Endocrinol Metab. 56:781-785.
6. Stenszky V, Kozma L, Balazs C, Rochlitz S, Bear JC, Farid NR. 1985 The genetics of Graves' disease: HLA and disease susceptibility. J Clin Endocrinol Metab. 61:735-740.
7. Badenhoop K, Walfish PG, Rau H, et al. 1995 Susceptibility and resistance alleles of human leukocyte antigen (HLA) DQA1 and HLA DQB1 are share in endocrine autoimmune disease. J Clin Endocrinol Metab. 80:2112-2117.
8. Boehm BO, Kuhnl P, Manfras BJ, et al. 1992 HLA-DRB3 gene alleles in Caucasian patients with Graves' disease. Clin Invest. 70:956-960.
9. Cuddihy RM, Bahn RS. 1996 Lack of an independent association between the HLA allele DQA1*0501 and Graves' disease. J Clin Endocrinol Metab. 81:847-849.
10. Semana G, Allanic H, Quillivic F, et al. 1990 Implications of the HLA-DRB3 gene in Graves' disease: predominance of allele Dw24. Hum Immunol. 29:143-149.
11. Yanagawa T, Mangklabruks A, Chang Y, et al. 1993 Human histocompatibility leukocyte antigen-DQA1*0501 allele associated with genetic susceptibility to Graves' disease in a Caucasian population. J Clin Endocrinol Metab. 76:1569-1574.
12. Yanagawa T, Mangklabruks A, DeGroot LJ. 1994 Strong association between HLA-DQA1*0501 and Graves' disease in a male Caucascian population. J Clin Endocrinol Metab. 79:227-229.
13. McLachlan SM. 1993 The genetic basis of autoimmune thyroid disease:time to focus on chromosomal loci other than the major histocompatibility complex (HLA in man). J Clin Endocrinol Metab. 77:605A-605C.
14. Cuddihy RM, Dutton CM, Bahn RS. 1995 A polymorphism in the extracellular domain of the thyrotropin receptor is highly associated with autoimmune thyroid disease in females. Thyroid. 5:89-95.
15. Heufelder AE, Bahn RS. 1993 Detection and localization of cytokine immunoreactivity in retro-ocular connective tissue in Graves' ophthalmopathy. Eur J Clin Invest. 31:10-17.
16. Korducki JM, Loftus SJ, Bahn RS. 1992 Stimulation of glycosaminoglycan production in cultured human retroocular fibroblasts. Invest Ophthalmol Vis Sci. 33:2037-2042.
17. Tan GH, Dutton CM, Bahn RS. 1996 Interleukin-1 receptor antagonist and soluble interleukin-1 receptor inhibit interleukin-1-induced glycosaminoglycan production by cultured human orbital fibroblasts in patients with Graves' ophthalmopathy. J Clin Endocrinol Metab. 81:449-452.
18. Blakemore AI, Watson PF, Weetman AP, Duff GW. 1995 Association of Graves' disease with an allele of the interleukin-1 receptor antagonist gene. J Clin Endocrinol Metab. 80:111-115.
19. Blakemore AI, Tarlow JK, Cork MJ, Gordon C, Emery P, Duff GW. 1994 Interleukin-1 receptor antagonist gene polymorphism as a disease severity factor in systemic lupus erythematosus. Arthritis Rheum. 37:1380-1385.
20. Mansfield JC, Holden H, Tarlow JK, et al. 1994 Novel genetic association between ulcerative colitis and the anti-inflammatory cytokine interleukin-1 receptor antagonist. Gastroenterology. 106:637-642.
21. Velden PA, Reitsma PH. 1993 Amino acid dimorphism in IL-1A is detectable by PCR amplification. Hum Mol Genet. 2:1753.
22. Kawashima H, Yamagishi J, Yamayoshi M, et al. 1992 Structure-activity relationships in human interleukin-1α: identification of key residues for expression of biological activities. Protein Engin. 5:171-176.
23. Bahn RS, Dutton CM, Heufelder AE, Sarkar G. 1994 A genomic point mutation in the extracellular domain of the thyrotropin receptor in patients with Graves' ophthalmopathy. J Clin Endocrinol Metab. 78:256-260.
24. Tarlow JK, Blakemore AIF, Lennard A, et al. 1993 Polymorphism in human IL-1 receptor antagonist gene intron 2 is caused by variable numbers of an 86-bp tandem repeat. Hum Genet. 91:403-404.
25. Tarlow JK, Clay FE, Cork MJ, et al. 1994 Severity of alopecia areata is associated with a polymorphism in the interleukin-1 receptor antagonist gene. J Invest Dermatol. 103:387-390.
26. Blakemore AIF, Cox A, Gonzalez A, et al. 1996 Interleukin-1 receptor antagonist allele (IL1RN*2) associated with nephropathy in diabetes mellitus. Hum Genet. 97:369-374.